CO86 Improving External Validity of Trial Outcomes When Estimating Subgroup QALY Gains: A Case Study of Pembrolizumab±Chemotherapy Vs. Cetuximab+Platinum-Based Chemotherapy (‘EXTREME’) in Squamous Cell Carcinoma of the Head and Neck

Autor: Bullement, A., Naik, J., Schlichting, M., Pescott, C.P.
Zdroj: In Value in Health June 2023 26(6) Supplement:S30-S30
Databáze: ScienceDirect
Externí odkaz: